Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0OR8W
|
||||
| Former ID |
DIB012163
|
||||
| Drug Name |
ETIPREDNOL DICLOACETATE
|
||||
| Synonyms |
BNP-166; Cronaze (Ivax); Ethinase (Ivax); Etiprednol dicloacetate < USAN; Prop INN >; Respicort (Ivax); (11beta,17alpha)-17-(2,2-Dichloroacetoxy)-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylic acid ethyl ester
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Rhinitis [ICD9: 472.0, 477; ICD10:J00, J30, J31.0] | Phase 2 | [1] | ||
| Company |
Teva Pharmaceutical USA
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C24H30Cl2O6
|
||||
| Canonical SMILES |
CCOC(=O)[C@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H<br />]3[C@@H](O)C[C@]12C)OC(=O)C(Cl)Cl
|
||||
| InChI |
1S/C24H30Cl2O6/c1-4-31-21(30)24(32-20(29)19(25)26)10-8-16-15-6-5-13-11-14(27)7-9-22(13,2)18(15)17(28)12-23(16,24)3/h7,9,11,15-19,28H,4-6,8,10,12H2,1-3H3/t15-,16-,17-,18+,22-,23-,24-/m0/s1
|
||||
| InChIKey |
QAIOVDNCIZSSSF-RFAJLIJZSA-N
|
||||
| CAS Number |
CAS 199331-40-3
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Glucocorticoid receptor | Target Info | Modulator | ||
| KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| FOXA2 and FOXA3 transcription factor networks | |||||
| Glucocorticoid receptor regulatory network | |||||
| Regulation of Androgen receptor activity | |||||
| AP-1 transcription factor network | |||||
| Reactome | BMAL1:CLOCK,NPAS2 activates circadian gene expression | ||||
| WikiPathways | Serotonin Receptor 4/6/7 and NR3C Signaling | ||||
| SIDS Susceptibility Pathways | |||||
| Nuclear Receptors Meta-Pathway | |||||
| Endoderm Differentiation | |||||
| Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||||
| Adipogenesis | |||||
| Circadian Clock | |||||
| Nuclear Receptors | |||||
| References | |||||
| REF 1 | ClinicalTrials.gov (NCT00035503) Multicenter Trial For Patients With Acute Crohn's Disease. U.S. National Institutes of Health. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.